Quotes 5-day view Delayed Nyse
11/20/2020
11/23/2020
11/24/2020
11/25/2020
11/27/2020
Date
232.54(c)
232.01(c)
224.68(c)
226.35(c)
230.16(c)
Last
288 038
220 668
265 393
188 973
73 048
Volume
-0.39% -0.23% -3.16% +0.74% +1.68% Change
Sales 2020
2 889 M - -
Net income 2020
296 M - -
Net Debt 2020
1 550 M - -
P/E ratio 2020
39,2x
Yield 2020
-
Sales 2021
3 181 M - -
Net income 2021
358 M - -
Net Debt 2021
1 136 M - -
P/E ratio 2021
32,7x
Yield 2021
-
Capitalization
11 449 M 11 449 M -
EV / Sales 2020
4,50x
EV / Sales 2021
3,96x
Nbr of Employees
17 100
Free-Float
98,2%
Charles River Laboratories International, Inc. is an early-stage contract research company. The Company is engaged in laboratory animal medicine and science (research model technologies) and develop a portfolio of discovery and safety assessment services, both good laboratory practice (GLP) and non-GLP, which supports its clients from target identification through non-clinical development. The Company operates in...
All news about CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
News in other languages on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
U.S. firms shield CEO pay as pandemic hits workers, investors
Chart CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Short Term Mid-Term Long Term Trends Neutral Bullish Bullish
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
BUY
Number of Analysts
18
Average target price
255,88 $
Last Close Price
230,16 $
Spread / Highest target
23,4%
Spread / Average Target
11,2%
Spread / Lowest Target
-32,7%
Please enable JavaScript in your browser's settings to use dynamic charts.
Canada
Deutschland
France
Schweiz (DE)
United Kingdom
Report
